Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer.
Juan-Ribelles A, Bautista F, Cañete A, Rubio-San-Simón A, Alonso-Saladrigues A, Hladun R, Rives S, Dapena JL, Fernández JM, Lassaletta Á, Cruz O, Ramírez-Villar G, Fuster JL, de Heredia CD, García-Ariza M, Quiroga E, Del Mar Andrés M, Verdú-Amorós J, Molinés A, Herrero B, López M, Márquez C, Toboso M, Lendínez F, Sirvent JG, Tallón M, Rodríguez G, Acha T, Moreno L, Fernández-Teijeiro A; Sociedad Española de Hematología y Oncología Pediátrica (SEHOP). Juan-Ribelles A, et al. Among authors: dapena jl. Clin Transl Oncol. 2024 Apr 10. doi: 10.1007/s12094-024-03445-0. Online ahead of print. Clin Transl Oncol. 2024. PMID: 38600340
ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in Spain.
Bautista F, Cañete A, Ramírez-Villar GL, Fernández JM, Fuster JL, Diaz de Heredia C, Astigarraga I, García-Ariza M, Rives S, Dapena JL, Márquez C, Molinés A, Bermúdez MDM, Gallego S, Andrés MDM, Verdu-Amoros J, Hernández C, López M, Catalá A, Lassaletta Á, Cruz O, Ramírez M, Lendínez F, Carboné A, Gomez Sirvent J, Tallón M, Acha T, Moreno L, Fernández-Teijeiro A; Sociedad Española de Hematología y Oncología Pediátrica (SEHOP). Bautista F, et al. Among authors: dapena jl. Clin Transl Oncol. 2019 Dec;21(12):1763-1770. doi: 10.1007/s12094-019-02221-9. Epub 2019 Oct 9. Clin Transl Oncol. 2019. PMID: 31598904 Free article.
Blinatumomab to improve the outcome of children with relapsed B-cell acute lymphoblastic leukemia.
Fuster JL, Bautista F, González B, Fernández JM, Rives S, Dapena JL; Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP). Fuster JL, et al. Among authors: dapena jl. Clin Transl Oncol. 2021 Sep;23(9):1963-1966. doi: 10.1007/s12094-021-02590-0. Epub 2021 Mar 19. Clin Transl Oncol. 2021. PMID: 33742341 No abstract available.
Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP).
Fuster JL, Molinos-Quintana A, Fuentes C, Fernández JM, Velasco P, Pascual T, Rives S, Dapena JL, Sisinni L, López-Godino O, Palomo P, Villa-Alcázar M, Bautista F, González-Vicent M, López-Duarte M, García-Morín M, Ramos-Elbal E, Ramírez M; Leukemia Working Group of the Spanish Society of Pediatric Hematology, Oncology (SEHOP). Fuster JL, et al. Among authors: dapena jl. Br J Haematol. 2020 Sep;190(5):764-771. doi: 10.1111/bjh.16647. Epub 2020 Apr 21. Br J Haematol. 2020. PMID: 32314348 Free article.
Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic.
Faura A, Rives S, Lassaletta Á, Sebastián E, Madero L, Huerta J, García-Morín M, Martínez AP, Sisinni L, Astigarraga I, Velasco P, Gros L, Moreno L, Carboné A, Rodríguez-Vigil C, Riesco S, Mendoza MDC, Macias EG, Trabazo M, Torrent M, Badell I, Fuster JL, Dominguez-Pinilla N, Juan Ribelles A, Pérez-Alonso V, Fernández Sanmartín M, Baragaño M, Gorostegui M, Perez-Jaume S, Fernández-Teijeiro A, Morales La Madrid A, Dapena JL. Faura A, et al. Among authors: dapena jl. Pediatr Blood Cancer. 2020 Sep;67(9):e28557. doi: 10.1002/pbc.28557. Epub 2020 Jul 16. Pediatr Blood Cancer. 2020. PMID: 32672895 Free PMC article. No abstract available.
Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet).
Moreno C, Ramos-Elbal E, Velasco P, Aguilar Y, Gonzáález Martínez B, Fuentes C, Molinos Á, Guerra-García P, Palomo P, Verdu J, Adán Pedroso RM, Vagace JM, López-Duarte M, Regueiro A, Tasso M, Dapena JL, Salinas JA, Navarro S, Bautista F, Lassaletta Á, Lendínez F, Rives S, Pascual A, Rodríguez A, Pérez-Hurtado JM, Fernández JM, Pérez-Martínez A, González-Vicent M, Díaz de Heredia C, Fuster JL. Moreno C, et al. Among authors: dapena jl. Front Pediatr. 2023 Mar 20;11:1140637. doi: 10.3389/fped.2023.1140637. eCollection 2023. Front Pediatr. 2023. PMID: 37020654 Free PMC article.
The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP).
Velasco P, Bautista F, Rubio A, Aguilar Y, Rives S, Dapena JL, Pérez A, Ramirez M, Saiz-Ladera C, Izquierdo E, Escudero A, Camós M, Vega-García N, Ortega M, Hidalgo-Gómez G, Palacio C, Menéndez P, Bueno C, Montero J, Romecín PA, Zazo S, Alvarez F, Parras J, Ortega-Sabater C, Chulián S, Rosa M, Cirillo D, García E, García J, Manzano-Muñoz A, Minguela A, Fuster JL. Velasco P, et al. Among authors: dapena jl. Front Pediatr. 2023 Sep 20;11:1269560. doi: 10.3389/fped.2023.1269560. eCollection 2023. Front Pediatr. 2023. PMID: 37800011 Free PMC article.
Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.
Vega-García N, Perez-Jaume S, Esperanza-Cebollada E, Vicente-Garcés C, Torrebadell M, Jiménez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sánchez-Garcia J, García-Calderón CB, Gómez-Casares MT, Martín-Clavero E, Escudero A, Riñón Martinez-Gallo M, Muñoz L, Velasco MR, García-Morin M, Català A, Pascual A, Velasco P, Fernández JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana Á, Molinés A, Guerra-García P, Pérez-Martínez A, García-Abós M, Robles Ortiz R, Pisa S, Adán R, Díaz de Heredia C, Dapena JL, Rives S, Ramírez-Orellana M, Camós M. Vega-García N, et al. Among authors: dapena jl. Front Pediatr. 2021 Feb 5;8:614521. doi: 10.3389/fped.2020.614521. eCollection 2020. Front Pediatr. 2021. PMID: 33614543 Free PMC article.
Lower incidence of clinical allergy with PEG-asparaginase upfront versus the sequential use of native E. coli asparaginase followed by PEG-ASP in pediatric patients with acute lymphoblastic leukemia.
Mesegué M, Alonso-Saladrigues A, Pérez-Jaume S, Comes-Escoda A, Dapena JL, Faura A, Conde N, Català A, Ruiz-Llobet A, Zapico-Muñiz E, Camós M, Rives S. Mesegué M, et al. Among authors: dapena jl. Hematol Oncol. 2021 Dec;39(5):687-696. doi: 10.1002/hon.2914. Epub 2021 Aug 16. Hematol Oncol. 2021. PMID: 34397119
29 results